The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 23, 2025

Filed:

Dec. 10, 2021
Applicants:

Institut DE Cardiologie DE Montreal, Montréal, CA;

Affina Biotechnologies, Inc., Valhalla, NY (US);

Inventors:

Alan Berezov, White Plains, NY (US);

Alexander Vinitsky, New York, NY (US);

Steve Poirier, Montréal, CA;

Gaétan Mayer, Montréal, CA;

Assignees:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/502 (2006.01); A61K 31/192 (2006.01); A61K 31/216 (2006.01); A61K 31/22 (2006.01); A61K 31/366 (2006.01); A61K 31/395 (2006.01); A61K 31/397 (2006.01); A61K 31/40 (2006.01); A61K 31/405 (2006.01); A61K 31/437 (2006.01); A61K 31/454 (2006.01); A61K 31/4545 (2006.01); A61K 31/47 (2006.01); A61K 31/4709 (2006.01); A61K 31/505 (2006.01); A61K 31/519 (2006.01); A61K 31/527 (2006.01); A61K 31/55 (2006.01); A61P 3/06 (2006.01); C07D 401/06 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/12 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 471/10 (2006.01); C07D 471/14 (2006.01); C07D 487/04 (2006.01); C07D 491/052 (2006.01);
U.S. Cl.
CPC ...
A61K 31/502 (2013.01); A61K 31/192 (2013.01); A61K 31/216 (2013.01); A61K 31/22 (2013.01); A61K 31/366 (2013.01); A61K 31/395 (2013.01); A61K 31/397 (2013.01); A61K 31/40 (2013.01); A61K 31/405 (2013.01); A61K 31/437 (2013.01); A61K 31/454 (2013.01); A61K 31/4545 (2013.01); A61K 31/47 (2013.01); A61K 31/4709 (2013.01); A61K 31/505 (2013.01); A61K 31/519 (2013.01); A61K 31/527 (2013.01); A61K 31/55 (2013.01); A61P 3/06 (2018.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 471/10 (2013.01); C07D 471/14 (2013.01); C07D 487/04 (2013.01); C07D 491/052 (2013.01);
Abstract

The present invention relates to compounds of Table 1, which are encompassed by Formula I and/or Formula II, Ill, IV, V, or VI, and pharmaceutically acceptable salts, solvates or compositions thereof. Compounds of Table 1 are PCSK9 interacting small molecules that modulate PCSK9 activity and significantly increase low density lipoprotein receptor expression and activity, lower total circulating cholesterol and are useful for treating and delaying the onset of diseases that are associated with elevated cholesterol.


Find Patent Forward Citations

Loading…